XEU:CA:TSX-iShares MSCI Europe IMI (CAD)

ETF | European Equity |

Last Closing

CAD 30.7

Change

-0.20 (-0.65)%

Market Cap

CAD 0.32B

Volume

5.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for European Equity

Symbol Name Price(Change) Market Cap
ZEQ:CA BMO MSCI Europe High Quality C..

-0.22 (-0.70%)

CAD 1.10B
ZWP:CA BMO Europe High Dividend Cover..

-0.11 (-0.60%)

CAD 0.78B
ZWE:CA BMO Europe High Dividend Cover..

-0.10 (-0.49%)

CAD 0.61B
VE:CA Vanguard FTSE Developed Europe..

-0.23 (-0.63%)

CAD 0.20B
XEH:CA iShares MSCI Europe IMI CAD He..

-0.13 (-0.39%)

CAD 0.14B
RPD:CA RBC Quant European Dividend Le..

N/A

CAD 0.03B
EDGF:CA Brompton European Dividend Gro..

+0.06 (+0.56%)

CAD 0.02B
RPDH:CA RBC Quant European Dividend Le..

-0.39 (-1.45%)

CAD 0.01B
EHE:CA CI Europe Hedged Equity Index ..

N/A

CAD 1.58M
HXX:CA Global X Europe 50 Index Corpo..

-0.38 (-0.73%)

N/A

ETFs Containing XEU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (European Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.78% 73% C 46% F
Dividend Return 2.26% 38% F 52% F
Total Return 12.04% 73% C 49% F
Trailing 12 Months  
Capital Gain 20.02% 82% B 53% F
Dividend Return 3.49% 63% D 58% F
Total Return 23.50% 91% A- 55% F
Trailing 5 Years  
Capital Gain 34.06% 73% C 59% D-
Dividend Return 12.74% 43% F 53% F
Total Return 46.81% 73% C 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.99% N/A N/A 61% D-
Dividend Return 9.28% N/A N/A 63% D
Total Return 2.29% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 14.80% N/A N/A 74% C
Risk Adjusted Return 62.71% N/A N/A 79% B-
Market Capitalization 0.32B 70% C- 52% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.